Searched for
BIOCON CEO APPOINTMENT
Intellectual curiosity & infectious optimism: Industry cheers Kunal Shah's new role as WhatsApp HeadIndia Inc. is celebrating Kunal Shah's appointment as WhatsApp head, hailing it as a milestone for Indian startup leadership. Industry lead...- Biocon Q4 Results: Net profit down 57% at Rs 198.6 croreBiocon Ltd reported a 56.8% drop in Q4 net profit to Rs 198.6 crore, impacted by an Rs 80.4 crore exceptional item. Despite this, consolida...
- Syngene shares zoom 17% even as firm’s Q4 net profit drops 19% YoY. What's driving the surge?Syngene shares surged despite a 19% YoY decline in Q4FY26 net profit to Rs 148 crore, as earnings rebounded sharply from Rs 15 crore in the...
- Biocon names insider Shreehas Tambe as MD & CEO for 5 years as Siddharth Mittal steps downBiocon announced a leadership change. Siddharth Mittal will step down as Managing Director and Chief Executive Officer on March 31. He will...
- ET Exclusive | Biologics merger with Biocon most value-accretive option: Kiran Mazumdar ShawBiocon is fully integrating Biocon Biologics, valuing its biosimilar business at $5.5 billion. This move removes debt concerns and improves...
- Syngene's MD & CEO Jonathan Hunt steps down, Peter Bains named as new CEOJonathan Hunt has stepped down as the managing director and CEO of Syngene International, with Peter Bains appointed as the CEO Designate e...
- Biocon Q4 Results: Net profit slumps 57% YoY to Rs 135 croreBiocon Q4 Results: Revenue from operations increased 16% year-on-year (YoY) to Rs 2,947 crore in the January-March 2024 period.
- Biocon Biologics completes integration of Viatris' biosimilar business in 120 countriesThe company said over 10 emerging markets along with Japan, Australia and New Zealand have transitioned in this final phase of the integrat...
- Biocon Biologics names Kedar Upadhye as new CFOUpadhye will be replace current CFO MB Chinappa who will take up strategic finance role at Biocon Group and will work with Peter Bains, the...
- New Group CEO is someone who understands Biocon's business synergy well: Kiran Mazumdar-Shaw"Peter, who is a veteran when it comes to the pharma and biopharma industry in terms of his global experience, also understands the Biocon ...
- Stocks in news: HDFC Bank, Torrent Pharma, Cipla, RIL, Biocon, Tata MotorsTorrent Pharmaceutical is in preliminary talks with Apollo Global Management to secure a loan of up to $1 billion to help fund a planned bi...
- Biocon appoints Peter Bains as Group CEO"I am delighted to welcome Peter to the Biocon Group in the role of Group CEO. Siddharth Mittal, CEO & MD Biocon Limited, Shreehas Tambe, C...
- Biocon Biologics announces top leadership appointmentsBiocon Biologics Ltd has made several key leadership appointments, including appointing Rhonda Duffy as Chief Operating Officer and Sandeep...
- Stocks in news: Zee Entertainment, Hero MotoCorp, Biocon, Greaves CottonOrient Cement has entered into a non-binding agreement with Adani Power Maharashtra for setting out the understanding for facilitating bona...
- Biocon Biologics appoints Shreehas Tambe as MD & CEOTambe has been with Biocon since 1997 and has held diverse leadership and operational roles. Over the past 25 years, he has helped build an...
- Biocon Biologics may close $3.34 billion Viatris deal in Q1Out of $2 billion, $800 million will come through equity infusion from existing investors including parent Biocon and others such as Serum ...
- Infosys appoints D Sundaram as independent directorThe appointment is based on the recommendations of the Nomination and Remuneration Committee of the Board, Infosys said in a statement.
- Syngene appoints Jonathan Hunt as CEO-designateHunt will take charge after the retirement of current CEO Peter Bains in March, Syngene International said in a regulatory filing.
- Biocon arm Syngene appoints Peter Bains as CEOBains has been a director of Syngene, since 2011. Syngene had yesterday said it would set up a new plant at Mangalore SEZ to manufacture ph...
- Biocon Q3 Net dips 13% to Rs 91 crore; to offload 10-15% in SyngeneBio-pharmaceuticals contributed Rs 541 crore and research services Rs 220 crore to revenue for the reporting quarter.
Load More
